CD4 and autoimmune disease: In addition, EI-03 was also showed to inhibit IFNγ production both in CD4+ T cells and in CD8+ T cells, implying that EI-03 may exhibit a more broad effect in controlling the function of DCs and the differentiation of T cell subsets for treatment of T cell-mediated autoimmune diseases.